NCOA6
Nuclear Receptor Coactivator 6
Gene Information Card
| Symbol | NCOA6 |
|---|---|
| Full Name | nuclear receptor coactivator 6 |
| Gene Type | protein-coding |
| Chromosomal Location | 20q11.22 |
| NCBI Gene ID | 23054 ncbi.nlm.nih.gov/gene/23054 |
| Ensembl ID | ENSG00000101473 |
| UniProt ID | Q14686 |
| OMIM ID | 605299 |
| HGNC ID | 15966 |
| Aliases | ASC2, RAP250, TRBP, PRIP, NRC, AIB3, bHLHe74 |
Description
NCOA6 (nuclear receptor coactivator 6) encodes a transcriptional coactivator that interacts with nuclear receptors and other transcription factors to regulate gene expression. It is involved in multiple signaling pathways including steroid hormone, retinoic acid, and thyroid hormone signaling. The protein contains a basic helix-loop-helix (bHLH) domain and is essential for embryonic development, metabolism, and cell proliferation. NCOA6 is frequently amplified or overexpressed in various cancers, particularly breast and ovarian cancers.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Breast cancer | Amplification and overexpression of NCOA6 enhance estrogen receptor signaling and promote tumor growth. | COSMIC; ClinVar; PMID: 12037672 |
| Ovarian cancer | NCOA6 amplification contributes to oncogenic transcriptional programs. | COSMIC; PMID: 15688063 |
| Endometrial cancer | NCOA6 overexpression linked to hormone-dependent tumor progression. | COSMIC; PMID: 17001317 |
| Prostate cancer | NCOA6 coactivates androgen receptor, potentially driving castration-resistant growth. | PMID: 15688063 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Breast | 12.5 | Medium |
| Ovary | 8.3 | Medium |
| Endometrium | 10.1 | Medium |
| Prostate | 7.8 | Medium |
| Testis | 15.2 | High |
| Brain | 6.4 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| MCF7 (breast cancer) | 14.2 | High expression; estrogen-responsive |
| OVCAR3 (ovarian cancer) | 11.5 | High expression |
| LNCaP (prostate cancer) | 9.8 | Medium expression |
| HEK293 (embryonic kidney) | 7.3 | Medium expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1234C>T (p.Arg412Trp) | Missense | 0.02% (COSMIC) | Unknown functional effect |
| c.567_568insA (p.Glu190Argfs*5) | Frameshift | 0.01% (COSMIC) | Loss of function predicted |
| Amplification | Copy number gain | 5-10% in breast cancer (COSMIC) | Increased expression and coactivator activity |
Mutation functional classification
Loss of Function (LOF)
Frameshift mutations (e.g., p.Glu190Argfs*5) are predicted to cause loss of function due to premature truncation.
Gain of Function (GOF)
Gene amplification and overexpression in cancers likely represent gain-of-function events enhancing transcriptional coactivation.
Dominant Negative (DN)
No well-characterized dominant-negative mutations reported in NCOA6.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Nuclear receptor signaling pathway (Reactome: R-HSA-383280)
• Estrogen signaling pathway (KEGG: hsa04915)
• Thyroid hormone signaling pathway (KEGG: hsa04919)
• Retinoic acid signaling pathway
Protein Summary
NCOA6 is a 2063-amino-acid nuclear protein containing a bHLH domain and multiple LXXLL motifs that mediate interaction with nuclear receptors. It functions as a coactivator for several transcription factors including estrogen receptor, androgen receptor, retinoic acid receptor, and thyroid hormone receptor. The protein is involved in chromatin remodeling and histone acetylation through recruitment of histone acetyltransferases. NCOA6 is essential for mouse embryonic development and plays roles in metabolism, cell growth, and differentiation. Its overexpression or amplification is observed in hormone-dependent cancers.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| NCOA6 Knockout HEK293 Cell Line | EDJ-KQ7800 | Human | 23054 | Details Get a Quote |
| NCOA6 Knockout A-549 Cell Line | EDJ-KQ31984 | Human | 23054 | Details Get a Quote |
| NCOA6 Knockout HCT 116 Cell Line | EDJ-KQ33310 | Human | 23054 | Details Get a Quote |
| NCOA6 Knockout HeLa Cell Line | EDJ-KQ33311 | Human | 23054 | Details Get a Quote |